Canine immune-mediated polyarthritis: part 1: pathophysiology
Kirstin C Johnson1, Andrew Mackin
1Department of Clinical Sciences, College of Veterinary Medicine, Mississippi State University, Mississippi, USA.
Journal of the American Animal Hospital Association
|December 23, 2011
Summary
Immune-mediated polyarthritis (IMPA) in dogs involves an immune system attack on joints. Understanding the pathophysiology of canine immune-mediated polyarthritis is key to effective treatment strategies.
Area of Science:
- Veterinary Immunology
- Canine Pathology
Background:
- Immune-mediated polyarthritis (IMPA) is a prevalent condition in dogs.
- IMPA is classified into erosive and nonerosive forms.
- Joint pathophysiology is crucial for effective canine IMPA management.
Purpose of the Study:
- To review the pathophysiology of immune-mediated polyarthritis in dogs.
- To provide foundational knowledge for the subsequent article on diagnosis and treatment.
Main Methods:
- Literature review of immune-mediated polyarthritis in canine medicine.
- Focus on the underlying mechanisms of joint immune attack.
Main Results:
- Detailed exploration of the pathophysiological processes in canine IMPA.
- Distinction between erosive and nonerosive immune-mediated polyarthropathies.
Conclusions:
- Understanding IMPA pathophysiology is essential for therapeutic decisions in dogs.
- This review sets the stage for a comprehensive guide on canine IMPA diagnosis and treatment.
Related Concept Videos
Acute Pancreatitis II: Pathophysiology
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


